Agilent Technologies, Inc. $A Shares Sold by Noesis Capital Mangement Corp

Noesis Capital Mangement Corp lowered its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 0.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 120,127 shares of the medical research company’s stock after selling 802 shares during the quarter. Agilent Technologies makes up approximately 2.5% of Noesis Capital Mangement Corp’s holdings, making the stock its 16th largest position. Noesis Capital Mangement Corp’s holdings in Agilent Technologies were worth $14,176,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its position in Agilent Technologies by 0.7% during the 1st quarter. Vanguard Group Inc. now owns 33,408,626 shares of the medical research company’s stock valued at $3,908,141,000 after purchasing an additional 240,965 shares during the period. Pictet Asset Management Holding SA boosted its position in Agilent Technologies by 2.5% during the 1st quarter. Pictet Asset Management Holding SA now owns 5,341,870 shares of the medical research company’s stock worth $624,888,000 after acquiring an additional 128,131 shares during the period. Generation Investment Management LLP boosted its position in Agilent Technologies by 19.8% during the 1st quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company’s stock worth $582,976,000 after acquiring an additional 824,243 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Agilent Technologies by 18.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock worth $448,748,000 after acquiring an additional 604,124 shares during the period. Finally, Nordea Investment Management AB boosted its position in Agilent Technologies by 16.2% during the 2nd quarter. Nordea Investment Management AB now owns 3,213,748 shares of the medical research company’s stock worth $383,143,000 after acquiring an additional 447,207 shares during the period.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Robert W. Baird boosted their price target on Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a research report on Thursday, August 28th. Weiss Ratings reiterated a “hold (c)” rating on shares of Agilent Technologies in a research report on Wednesday, October 8th. Wells Fargo & Company boosted their price target on Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a research report on Monday, September 15th. Rothschild Redb upgraded Agilent Technologies to a “strong-buy” rating in a research report on Wednesday, October 8th. Finally, Rothschild & Co Redburn assumed coverage on Agilent Technologies in a research report on Wednesday, October 8th. They set a “buy” rating and a $165.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $149.62.

Agilent Technologies Stock Down 1.9%

A opened at $143.15 on Thursday. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $153.84. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. The stock’s fifty day moving average is $131.95 and its 200-day moving average is $120.31. The company has a market capitalization of $40.58 billion, a PE ratio of 33.60, a P/E/G ratio of 4.76 and a beta of 1.26.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting analysts’ consensus estimates of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the previous year, the business earned $1.32 EPS. The company’s quarterly revenue was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th were paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 30th. Agilent Technologies’s payout ratio is currently 23.24%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.